Cargando…
Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials
BACKGROUND: The pharmacokinetics and pharmacodynamics of vaginal microbicides are typically assessed among sexually abstinent women. However, the physical act of sex may modulate gel distribution, and preclinical studies demonstrate seminal plasma interferes with the antiviral activity of several mi...
Autores principales: | Keller, Marla J., Mesquita, Pedro M. M., Torres, N. Merna, Cho, Sylvia, Shust, Gail, Madan, Rebecca P., Cohen, Hillel W., Petrie, Julie, Ford, Tara, Soto-Torres, Lydia, Profy, Albert T., Herold, Betsy C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809740/ https://www.ncbi.nlm.nih.gov/pubmed/20107502 http://dx.doi.org/10.1371/journal.pone.0008781 |
Ejemplares similares
-
A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel
por: Keller, Marla J., et al.
Publicado: (2011) -
Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel
por: Chirenje, Zvavahera M, et al.
Publicado: (2012) -
Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India
por: Smita, Joshi, et al.
Publicado: (2006) -
Postcoital bleeding
por: Ardestani, Shakiba, et al.
Publicado: (2023) -
Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
por: Segarra, Theodore J., et al.
Publicado: (2011)